Showing results (11-20 of 17) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
British Journal of Haematology|March 25, 2017
Carfilzomib induces leukaemia cell apoptosis via inhibiting ELK1/KIAA1524 (Elk-1/CIP2A) and activating PP2A not related to proteasome inhibitionChun-Yu Liu, Feng-Shu Hsieh, Pei-Yi Chu, et al.Molecular Oncology|January 14, 2017
Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cellsChun-Yu Liu, Jung-Chen Su, Tzu-Ting Huang, et al.Bioconjugate Chemistry|November 4, 2015
Development and Characterization of the Recombinant Human VEGF-EGF Dual-Targeting Fusion Protein as a Drug Delivery SystemJia-Je Li, Keng-Li Lan, Shun-Fu Chang, et al.Oncotarget|January 30, 2016
Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cellsChun-Yu Liu, Ming-Hung Hu, Chia-Jung Hsu, et al.Experimental & Molecular Medicine|August 12, 2017
The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cellsChun-Yu Liu, Tzu-Ting Huang, Pei-Yi Chu, et al.European Journal of Cancer (Oxford, England : 1990)|December 28, 2016
EGFR-independent Elk1/CIP2A signalling mediates apoptotic effect of an erlotinib derivative TD52 in triple-negative breast cancer cellsChun-Yu Liu, Tzu-Ting Huang, Chun-Teng Huang, et al.Journal of Molecular Medicine (Berlin, Germany)|June 5, 2017
Sequential combination of docetaxel with a SHP-1 agonist enhanced suppression of p-STAT3 signaling and apoptosis in triple negative breast cancer cellsChun-Yu Liu, Kuen-Feng Chen, Tzu-I Chao, et al.Pageof 2